Accepted at 5:33 p.m. Feb, 04, 2024 by Eli.Tanenbaum
Author: Eli.Tanenbaum
Related Note: 1481331145178
Rationale for change

aesthetics

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::02_Myeloproliferative_Disorders::Extra #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::02_Chronic_Leukemias_SOAP #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #PANCE::HEME::neoplasms_premalignancies_malignancies #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::*Chronic_Myeloproliferative_Disorders::Chronic_Myelogenous_Leukemia #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::02_Acute_Myeloid_Leukemia_(AML)_&_Chronic_Myeloid_Leukemia_(CML) #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::04_Chronic_Myelogenous_Leukemia_(CML) #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::02_Chronic_Myeloid_Leukemia #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::13_Myeloproliferative_Neoplasias_(MPN) #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::#B&B::12_Hematology::03_White_Blood_Cells::07_Myeloproliferative_Disorders #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::09_Oncogenes_and_Tumor_Suppressor_Genes #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Other::Only_Step_1&2_Overlap